COMBINATION CHEMOTHERAPY WITH MITOMYCIN AND VINDESINE IN ADVANCED NON-SMALL CELL LUNG-CANCER - A PILOT-STUDY BY THE LUNG-CANCER WORKING PARTY (BELGIUM)

被引：0
|
作者：
SCULIER, JP
KLASTERSKY, J
DUMONT, JP
VANDERMOTEN, G
ROCMANS, P
LIBERT, P
RAVEZ, P
BECQUART, D
MOMMEN, P
DALESIO, O
机构：
[1] INST JULES BORDET, 1 RUE HEGER BORDET, B-1000 BRUSSELS, BELGIUM
[2] ACAD ZIEKENHUIS MIDDELHEIM, ANTWERPEN, BELGIUM
[3] ACAD ZIEKENHUIS ANTWERPEN, ANTWERPEN, BELGIUM
[4] HOP WARQUIGNIES, BOUSSU, BELGIUM
[5] HOP ERASME, BRUXELLES, BELGIUM
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The combination of mitomycin plus vindesine in advanced non-small cell lung cancer induced an objective response rate of 23% in 43 evaluable patients: 33% in nonpretreated patients (nine response among 27 patients) and 6% in pretreated patients (one response among 16 patients). Toxicity was tolerable. We conclude that the regimen was a moderately active and easy to administer treatment for advanced non-small cell lung cancer.
引用
收藏
页码：773 / 775
页数：3
相关论文
共 50 条
  • [31] COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C, VINDESINE, AND IFOSFAMIDE IN THE TREATMENT OF INOPERABLE NON-SMALL-CELL LUNG-CANCER
    GATZEMEIER, U
    HOSSFELD, DK
    RADENBACH, D
    ZSCHABER, R
    ONKOLOGIE, 1985, 8 (04): : 208 - 212
  • [32] CIS-PLATINUM AND VINDESINE IN COMBINATION IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER
    CARMICHAEL, J
    GREGOR, A
    CORNBLEET, MA
    ALLAN, SG
    MCINTYRE, MA
    GRANT, IWB
    COMPTON, GK
    LEONARD, RCF
    SMYTH, JF
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (07): : 811 - 814
  • [33] PHASE II STUDY OF VINDESINE IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    FUJITA, J
    SAIJO, N
    EGUCHI, K
    SHINKAI, T
    TOMINAGA, K
    SASAKI, Y
    FUTAMI, H
    SAKURAI, M
    ISHIHARA, J
    TAKAHASHI, H
    HOSHI, A
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (09): : 902 - 905
  • [34] PILOT-STUDY OF NEOADJUVANT IFOSFAMIDE, CISPLATIN, AND ETOPOSIDE IN LOCALLY ADVANCED NON-SMALL CELL LUNG-CANCER
    PUJOL, JL
    ROSSI, JF
    LECHEVALIER, T
    DAURES, JP
    ROUANET, P
    DOUILLARD, JY
    DUBOIS, JB
    ARRIAGADA, R
    MARY, H
    GODARD, P
    MICHEL, FB
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 798 - 801
  • [35] CHEMOTHERAPY FOR CEREBRAL METASTASES IN SMALL CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC)
    TWELVES, C
    SOUHAMI, R
    HARPER, P
    TOBIAS, J
    SPIRO, S
    GEDDES, D
    ASH, C
    DRAKE, J
    THORAX, 1988, 43 (10) : P841 - P841
  • [36] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER
    CULLEN, MH
    CHETIYAWARDANA, AD
    JOSHI, R
    WOODROFFE, CM
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 893 - 893
  • [37] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER
    CULLEN, MH
    CHETIYAWARDANA, AD
    JOSHI, R
    WOODROFFE, CM
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 259 - 259
  • [38] CHEMOTHERAPY FOR UNRESECTABLE NON-SMALL CELL LUNG-CANCER
    JOHNSON, DH
    SEMINARS IN ONCOLOGY, 1990, 17 (04) : 20 - 29
  • [39] CHEMOTHERAPY IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER
    WEISS, RC
    COMIS, RL
    CANCER INVESTIGATION, 1986, 4 (04) : 343 - 351
  • [40] CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (07): : 1035 - 1038
12345